 | • レポートコード：D005-04892 • 出版社/出版日：GlobalInfoResearch / 2020年5月22日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、認知症薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。認知症薬の種類別市場規模（MAO阻害剤、コリンエステラーゼ阻害剤、グルタミン酸阻害剤）、用途別市場規模（病院薬局、小売薬局、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Eisai, Inc、AstraZeneca GmbH、Forest Laboratories, Inc、Janssen Pharmaceuticals, Inc、Sanofi S.A、Biogen Pharmaceuticals、Merck & Co., Inc、Novartis AG、Eli Lilly and Company、F. Hoffmann-La Roche、Valeant Pharmaceutical International、Pfizer Inc、Teva Pharmaceuticals Industries ・地域別グローバル市場分析 2015年-2020年 ・認知症薬の北米市場（アメリカ、カナダ、メキシコ） ・認知症薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・認知症薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・認知症薬の南米市場（ブラジル、アルゼンチン） ・認知症薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：MAO阻害剤、コリンエステラーゼ阻害剤、グルタミン酸阻害剤 ・用途別分析：病院薬局、小売薬局、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Dementia Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.6% in the forecast period of 2020 to 2025 and will expected to reach USD 16380 million by 2025, from USD 13710 million in 2019.
The Dementia Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Dementia Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Dementia Drugs market has been segmented into
MAO Inhibitors
Cholinesterase Inhibitors
Glutamate Inhibitors
By Application, Dementia Drugs has been segmented into:
Hospital Pharmacies
Retail Pharmacies
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Dementia Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Dementia Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Dementia Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Dementia Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Dementia Drugs Market Share Analysis
Dementia Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Dementia Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Dementia Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Dementia Drugs are:
Eisai, Inc
AstraZeneca GmbH
Forest Laboratories, Inc
Janssen Pharmaceuticals, Inc
Sanofi S.A
Biogen Pharmaceuticals
Merck & Co., Inc
Novartis AG
Eli Lilly and Company
F. Hoffmann-La Roche
Valeant Pharmaceutical International
Pfizer Inc
Teva Pharmaceuticals Industries
Among other players domestic and global, Dementia Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dementia Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Dementia Drugs, with price, sales, revenue and global market share of Dementia Drugs in 2018 and 2019.
Chapter 3, the Dementia Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dementia Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Dementia Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Dementia Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Dementia Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Dementia Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 MAO Inhibitors
1.2.3 Cholinesterase Inhibitors
1.2.4 Glutamate Inhibitors
1.3 Market Analysis by Application
1.3.1 Overview: Global Dementia Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Others
1.4 Overview of Global Dementia Drugs Market
1.4.1 Global Dementia Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Eisai, Inc
2.1.1 Eisai, Inc Details
2.1.2 Eisai, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Eisai, Inc SWOT Analysis
2.1.4 Eisai, Inc Product and Services
2.1.5 Eisai, Inc Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 AstraZeneca GmbH
2.2.1 AstraZeneca GmbH Details
2.2.2 AstraZeneca GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 AstraZeneca GmbH SWOT Analysis
2.2.4 AstraZeneca GmbH Product and Services
2.2.5 AstraZeneca GmbH Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Forest Laboratories, Inc
2.3.1 Forest Laboratories, Inc Details
2.3.2 Forest Laboratories, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Forest Laboratories, Inc SWOT Analysis
2.3.4 Forest Laboratories, Inc Product and Services
2.3.5 Forest Laboratories, Inc Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Janssen Pharmaceuticals, Inc
2.4.1 Janssen Pharmaceuticals, Inc Details
2.4.2 Janssen Pharmaceuticals, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Janssen Pharmaceuticals, Inc SWOT Analysis
2.4.4 Janssen Pharmaceuticals, Inc Product and Services
2.4.5 Janssen Pharmaceuticals, Inc Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sanofi S.A
2.5.1 Sanofi S.A Details
2.5.2 Sanofi S.A Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Sanofi S.A SWOT Analysis
2.5.4 Sanofi S.A Product and Services
2.5.5 Sanofi S.A Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Biogen Pharmaceuticals
2.6.1 Biogen Pharmaceuticals Details
2.6.2 Biogen Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Biogen Pharmaceuticals SWOT Analysis
2.6.4 Biogen Pharmaceuticals Product and Services
2.6.5 Biogen Pharmaceuticals Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Merck & Co., Inc
2.7.1 Merck & Co., Inc Details
2.7.2 Merck & Co., Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Merck & Co., Inc SWOT Analysis
2.7.4 Merck & Co., Inc Product and Services
2.7.5 Merck & Co., Inc Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Novartis AG
2.8.1 Novartis AG Details
2.8.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Novartis AG SWOT Analysis
2.8.4 Novartis AG Product and Services
2.8.5 Novartis AG Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Eli Lilly and Company
2.9.1 Eli Lilly and Company Details
2.9.2 Eli Lilly and Company Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Eli Lilly and Company SWOT Analysis
2.9.4 Eli Lilly and Company Product and Services
2.9.5 Eli Lilly and Company Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 F. Hoffmann-La Roche
2.10.1 F. Hoffmann-La Roche Details
2.10.2 F. Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 F. Hoffmann-La Roche SWOT Analysis
2.10.4 F. Hoffmann-La Roche Product and Services
2.10.5 F. Hoffmann-La Roche Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Valeant Pharmaceutical International
2.11.1 Valeant Pharmaceutical International Details
2.11.2 Valeant Pharmaceutical International Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Valeant Pharmaceutical International SWOT Analysis
2.11.4 Valeant Pharmaceutical International Product and Services
2.11.5 Valeant Pharmaceutical International Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Pfizer Inc
2.12.1 Pfizer Inc Details
2.12.2 Pfizer Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Pfizer Inc SWOT Analysis
2.12.4 Pfizer Inc Product and Services
2.12.5 Pfizer Inc Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Teva Pharmaceuticals Industries
2.13.1 Teva Pharmaceuticals Industries Details
2.13.2 Teva Pharmaceuticals Industries Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Teva Pharmaceuticals Industries SWOT Analysis
2.13.4 Teva Pharmaceuticals Industries Product and Services
2.13.5 Teva Pharmaceuticals Industries Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Dementia Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Dementia Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Dementia Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Dementia Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Dementia Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Dementia Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Dementia Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Dementia Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Dementia Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Dementia Drugs Sales and Growth Rate (2015-2020)
4.5 South America Dementia Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Dementia Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Dementia Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Dementia Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Dementia Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Dementia Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Dementia Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Dementia Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Dementia Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Dementia Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Dementia Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Dementia Drugs Sales and Growth Rate (2015-2020)
6.3 UK Dementia Drugs Sales and Growth Rate (2015-2020)
6.4 France Dementia Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Dementia Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Dementia Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Dementia Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Dementia Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Dementia Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Dementia Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Dementia Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Dementia Drugs Sales and Growth Rate (2015-2020)
7.5 India Dementia Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Dementia Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Dementia Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Dementia Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Dementia Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Dementia Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Dementia Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Dementia Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Dementia Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Dementia Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Dementia Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Dementia Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Dementia Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Dementia Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Dementia Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Dementia Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Dementia Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Dementia Drugs Price by Type (2015-2020)
11 Global Dementia Drugs Market Segment by Application
11.1 Global Dementia Drugs Sales Market Share by Application (2015-2020)
11.2 Global Dementia Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Dementia Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Dementia Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Dementia Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Dementia Drugs Market Forecast (2021-2025)
12.2.2 Europe Dementia Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Dementia Drugs Market Forecast (2021-2025)
12.2.4 South America Dementia Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Dementia Drugs Market Forecast (2021-2025)
12.3 Dementia Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Dementia Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Dementia Drugs Market Share Forecast by Type (2021-2025)
12.4 Dementia Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Dementia Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Dementia Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Dementia Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Dementia Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Dementia Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Eisai, Inc Basic Information, Manufacturing Base and Competitors
Table 8. Eisai, Inc Dementia Drugs Major Business
Table 9. Eisai, Inc Dementia Drugs Total Revenue (USD Million) (2017-2018)
Table 10. Eisai, Inc SWOT Analysis
Table 11. Eisai, Inc Dementia Drugs Product and Services
Table 12. Eisai, Inc Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. AstraZeneca GmbH Basic Information, Manufacturing Base and Competitors
Table 14. AstraZeneca GmbH Dementia Drugs Major Business
Table 15. AstraZeneca GmbH Dementia Drugs Total Revenue (USD Million) (2017-2018)
Table 16. AstraZeneca GmbH SWOT Analysis
Table 17. AstraZeneca GmbH Dementia Drugs Product and Services
Table 18. AstraZeneca GmbH Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Forest Laboratories, Inc Basic Information, Manufacturing Base and Competitors
Table 20. Forest Laboratories, Inc Dementia Drugs Major Business
Table 21. Forest Laboratories, Inc Dementia Drugs Total Revenue (USD Million) (2017-2018)
Table 22. Forest Laboratories, Inc SWOT Analysis
Table 23. Forest Laboratories, Inc Dementia Drugs Product and Services
Table 24. Forest Laboratories, Inc Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Janssen Pharmaceuticals, Inc Basic Information, Manufacturing Base and Competitors
Table 26. Janssen Pharmaceuticals, Inc Dementia Drugs Major Business
Table 27. Janssen Pharmaceuticals, Inc Dementia Drugs Total Revenue (USD Million) (2017-2018)
Table 28. Janssen Pharmaceuticals, Inc SWOT Analysis
Table 29. Janssen Pharmaceuticals, Inc Dementia Drugs Product and Services
Table 30. Janssen Pharmaceuticals, Inc Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Sanofi S.A Basic Information, Manufacturing Base and Competitors
Table 32. Sanofi S.A Dementia Drugs Major Business
Table 33. Sanofi S.A Dementia Drugs Total Revenue (USD Million) (2017-2018)
Table 34. Sanofi S.A SWOT Analysis
Table 35. Sanofi S.A Dementia Drugs Product and Services
Table 36. Sanofi S.A Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Biogen Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 38. Biogen Pharmaceuticals Dementia Drugs Major Business
Table 39. Biogen Pharmaceuticals Dementia Drugs Total Revenue (USD Million) (2017-2018)
Table 40. Biogen Pharmaceuticals SWOT Analysis
Table 41. Biogen Pharmaceuticals Dementia Drugs Product and Services
Table 42. Biogen Pharmaceuticals Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Merck & Co., Inc Basic Information, Manufacturing Base and Competitors
Table 44. Merck & Co., Inc Dementia Drugs Major Business
Table 45. Merck & Co., Inc Dementia Drugs Total Revenue (USD Million) (2017-2018)
Table 46. Merck & Co., Inc SWOT Analysis
Table 47. Merck & Co., Inc Dementia Drugs Product and Services
Table 48. Merck & Co., Inc Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 50. Novartis AG Dementia Drugs Major Business
Table 51. Novartis AG Dementia Drugs Total Revenue (USD Million) (2017-2018)
Table 52. Novartis AG SWOT Analysis
Table 53. Novartis AG Dementia Drugs Product and Services
Table 54. Novartis AG Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 56. Eli Lilly and Company Dementia Drugs Major Business
Table 57. Eli Lilly and Company Dementia Drugs Total Revenue (USD Million) (2017-2018)
Table 58. Eli Lilly and Company SWOT Analysis
Table 59. Eli Lilly and Company Dementia Drugs Product and Services
Table 60. Eli Lilly and Company Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 62. F. Hoffmann-La Roche Dementia Drugs Major Business
Table 63. F. Hoffmann-La Roche Dementia Drugs Total Revenue (USD Million) (2017-2018)
Table 64. F. Hoffmann-La Roche SWOT Analysis
Table 65. F. Hoffmann-La Roche Dementia Drugs Product and Services
Table 66. F. Hoffmann-La Roche Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Valeant Pharmaceutical International Basic Information, Manufacturing Base and Competitors
Table 68. Valeant Pharmaceutical International Dementia Drugs Major Business
Table 69. Valeant Pharmaceutical International Dementia Drugs Total Revenue (USD Million) (2017-2018)
Table 70. Valeant Pharmaceutical International SWOT Analysis
Table 71. Valeant Pharmaceutical International Dementia Drugs Product and Services
Table 72. Valeant Pharmaceutical International Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 74. Pfizer Inc Dementia Drugs Major Business
Table 75. Pfizer Inc Dementia Drugs Total Revenue (USD Million) (2017-2018)
Table 76. Pfizer Inc SWOT Analysis
Table 77. Pfizer Inc Dementia Drugs Product and Services
Table 78. Pfizer Inc Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Teva Pharmaceuticals Industries Basic Information, Manufacturing Base and Competitors
Table 80. Teva Pharmaceuticals Industries Dementia Drugs Major Business
Table 81. Teva Pharmaceuticals Industries Dementia Drugs Total Revenue (USD Million) (2017-2018)
Table 82. Teva Pharmaceuticals Industries SWOT Analysis
Table 83. Teva Pharmaceuticals Industries Dementia Drugs Product and Services
Table 84. Teva Pharmaceuticals Industries Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Global Dementia Drugs Sales by Manufacturer (2018-2019) (K Units)
Table 86. Global Dementia Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 87. Global Dementia Drugs Sales by Regions (2015-2020) (K Units)
Table 88. Global Dementia Drugs Sales Market Share by Regions (2015-2020)
Table 89. Global Dementia Drugs Revenue by Regions (2015-2020) (USD Million)
Table 90. North America Dementia Drugs Sales by Countries (2015-2020) (K Units)
Table 91. North America Dementia Drugs Sales Market Share by Countries (2015-2020)
Table 92. North America Dementia Drugs Revenue by Countries (2015-2020) (USD Million)
Table 93. North America Dementia Drugs Revenue Market Share by Countries (2015-2020)
Table 94. Europe Dementia Drugs Sales by Countries (2015-2020) (K Units)
Table 95. Europe Dementia Drugs Sales Market Share by Countries (2015-2020)
Table 96. Europe Dementia Drugs Revenue by Countries (2015-2020) (USD Million)
Table 97. Asia-Pacific Dementia Drugs Sales by Regions (2015-2020) (K Units)
Table 98. Asia-Pacific Dementia Drugs Sales Market Share by Regions (2015-2020)
Table 99. Asia-Pacific Dementia Drugs Revenue by Regions (2015-2020) (USD Million)
Table 100. South America Dementia Drugs Sales by Countries (2015-2020) (K Units)
Table 101. South America Dementia Drugs Sales Market Share by Countries (2015-2020)
Table 102. South America Dementia Drugs Revenue by Countries (2015-2020) (USD Million)
Table 103. South America Dementia Drugs Revenue Market Share by Countries (2015-2020)
Table 104. Middle East & Africa Dementia Drugs Sales by Countries (2015-2020) (K Units)
Table 105. Middle East & Africa Dementia Drugs Sales Market Share by Countries (2015-2020)
Table 106. Middle East & Africa Dementia Drugs Revenue by Countries (2015-2020) (USD Million)
Table 107. Middle East & Africa Dementia Drugs Revenue Market Share by Countries (2015-2020)
Table 108. Global Dementia Drugs Sales by Type (2015-2020) (K Units)
Table 109. Global Dementia Drugs Sales Share by Type (2015-2020)
Table 110. Global Dementia Drugs Revenue by Type (2015-2020) (USD Million)
Table 111. Global Dementia Drugs Revenue Share by Type (2015-2020)
Table 112. Global Dementia Drugs Sales by Application (2015-2020) (K Units)
Table 113. Global Dementia Drugs Sales Share by Application (2015-2020)
Table 114. Global Dementia Drugs Sales Forecast by Regions (2021-2025) (K Units)
Table 115. Global Dementia Drugs Market Share Forecast by Regions (2021-2025)
Table 116. Global Dementia Drugs Sales Forecast by Type (2021-2025) (K Units)
Table 117. Global Dementia Drugs Market Share Forecast by Type (2021-2025)
Table 118. Global Dementia Drugs Sales Forecast by Application (2021-2025)
Table 119. Global Dementia Drugs Market Share Forecast by Application (2021-2025)
Table 120. Direct Channel Pros & Cons
Table 121. Indirect Channel Pros & Cons
Table 122. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Dementia Drugs Picture
Figure 2. Global Sales Market Share of Dementia Drugs by Type in 2019
Figure 3. MAO Inhibitors Picture
Figure 4. Cholinesterase Inhibitors Picture
Figure 5. Glutamate Inhibitors Picture
Figure 6. Dementia Drugs Sales Market Share by Application in 2018
Figure 7. Hospital Pharmacies Picture
Figure 8. Retail Pharmacies Picture
Figure 9. Others Picture
Figure 10. Global Dementia Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Dementia Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Dementia Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Dementia Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Dementia Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Dementia Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Dementia Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Dementia Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Dementia Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Dementia Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Dementia Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Dementia Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Dementia Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Dementia Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Dementia Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Dementia Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Dementia Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Dementia Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Dementia Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Dementia Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Dementia Drugs Sales Market Share by Manufacturer in 2019
Figure 31. Global Dementia Drugs Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Dementia Drugs Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Dementia Drugs Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Dementia Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 36. Global Dementia Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Dementia Drugs Revenue Market Share by Regions (2015-2020)
Figure 38. Global Dementia Drugs Revenue Market Share by Regions in 2018
Figure 39. North America Dementia Drugs Sales and Growth Rate (2015-2020)
Figure 40. Europe Dementia Drugs Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Dementia Drugs Sales and Growth Rate (2015-2020)
Figure 42. South America Dementia Drugs Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Dementia Drugs Sales and Growth Rate (2015-2020)
Figure 44. North America Dementia Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Dementia Drugs Sales Market Share by Countries (2015-2020)
Figure 46. North America Dementia Drugs Sales Market Share by Countries in 2018
Figure 47. North America Dementia Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Dementia Drugs Revenue Market Share by Countries in 2018
Figure 49. United States Dementia Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Canada Dementia Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Mexico Dementia Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Europe Dementia Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Dementia Drugs Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Dementia Drugs Revenue Market Share by Countries in 2019
Figure 55. Germany Dementia Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 56. UK Dementia Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 57. France Dementia Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Russia Dementia Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Italy Dementia Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Asia-Pacific Dementia Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Dementia Drugs Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Dementia Drugs Revenue Market Share by Regions 2019
Figure 63. China Dementia Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Japan Dementia Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Korea Dementia Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 66. India Dementia Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Southeast Asia Dementia Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 68. South America Dementia Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Dementia Drugs Sales Market Share by Countries in 2019
Figure 70. South America Dementia Drugs Revenue Market Share by Countries in 2019
Figure 71. Brazil Dementia Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Argentina Dementia Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Middle East and Africa Dementia Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Dementia Drugs Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Dementia Drugs Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Dementia Drugs Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Dementia Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Egypt Dementia Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Turkey Dementia Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 80. South Africa Dementia Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Global Dementia Drugs Sales and Growth Rate (2021-2025) (K Units)
Figure 82. Global Dementia Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Dementia Drugs Market Forecast (2021-2025) (K Units)
Figure 84. Europe Sales Dementia Drugs Market Forecast (2021-2025) (K Units)
Figure 85. Asia-Pacific Sales Dementia Drugs Market Forecast (2021-2025) (K Units)
Figure 86. South America Sales Dementia Drugs Market Forecast (2021-2025) (K Units)
Figure 87. Middle East & Africa Sales Dementia Drugs Market Forecast (2021-2025) (K Units)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
化学療法誘発悪心＆嘔吐（CINV）用薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2…- コレステロール低下薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Cholesterol-Lowering Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.7% in the forecast period of 2020 to 2025 and will expected to reach USD 19930 million by 2025, from USD 17940 million in 2019. The Cholesterol…
- バルビツール酸系薬物の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Barbiturate Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Barbiturate Drugs market re…
- ジペプチジルペプチダーゼIV（DPP-IV）阻害剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The D…
- 自殺防止薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Anti-Suicide Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.2% in the forecast period of 2020 to 2025 and will expected to reach USD 3696 million by 2025, from USD 3384.6 million in 2019. The Anti-Suicide Drugs …